HBM HOLDINGS-B (02142) spent HK$2.1441 million to repurchase 164,000 shares on May 11th.
Bo Medical-B (02142) announced that on May 11, 2026, it will spend HK$2.1441 million to repurchase 164,000 shares. It issued 87,000 common shares to fulfill the share incentive plan adopted and approved by the shareholders on November 23, 2020 after the initial public offering.
HBM Holdings-B (02142) announced that on May 11, 2026, it has spent 2.1441 million Hong Kong dollars to repurchase 164,000 shares. The company issued 87,000 common shares in accordance with the Share Incentive Plan adopted and approved by the company's shareholders on November 23, 2020.
Related Articles
JST GROUP (06687) spent 1.9975 million Hong Kong dollars to repurchase 12.88 thousand shares on May 11th.
Shenzhen Sunxing Light Alloys Materials (603978.SH): "Construction and completion of the third phase of the project to produce 15,000 tons of lithium hexafluorophosphate per year."
China Galaxy (06881) successfully issued 6 billion yuan corporate bonds.
JST GROUP (06687) spent 1.9975 million Hong Kong dollars to repurchase 12.88 thousand shares on May 11th.
Shenzhen Sunxing Light Alloys Materials (603978.SH): "Construction and completion of the third phase of the project to produce 15,000 tons of lithium hexafluorophosphate per year."
China Galaxy (06881) successfully issued 6 billion yuan corporate bonds.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
